Loading
CT
Cytophage Technologies Ltd. Stock: price and insider trades · Canada
Cytophage Technologies Ltd.: what insiders have been doing
Every trade that managers of Cytophage Technologies Ltd. disclose to SEDI is tracked on this page. 2 insiders have disclosed 2 filings since 22 October 2025.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
No insider has bought Cytophage Technologies Ltd. shares on the open market in the past twelve months.
With 2 filings in twelve months, the company is quieter than the median of 12 filings across the 2,472 companies we follow on the same exchange. Looking back to 2024, when coverage begins, insiders filed 15 purchases and 1 sale.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
48
Thresholds
n/a
Buy Volume
€193,410
15 ops. · all time
Sell Volume
€5,305
1 ops. · all time
Who traded when
BuySaleNatasha Helena Theriault1 buy
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 12 November 2025
Declarations48 total
25,000 shares@ CA$0.20100.0% of flowCommon SharesTSXSEDI:4604674
125,000 shares@ CA$0.20100.0% of flowCommon SharesTSXSEDI:4604647
75,000 shares@ CA$0.20100.0% of flowCommon SharesTSXSEDI:4563873
Common SharesTSXSEDI:4561089
100,000 sharesCommon SharesTSXSEDI:4561113
Common SharesTSXSEDI:4561022
100,000 sharesCommon SharesTSXSEDI:4561132
100,000 sharesCommon SharesTSXSEDI:4561103
Common SharesTSXSEDI:4561127
500,000 shares@ CA$0.40100.0% of flowCommon SharesTSXSEDI:4561025
Canonical exit: 8 Sept 2025 (T+90)
50,000 shares@ CA$0.35100.0% of flowCommon SharesTSXSEDI:4561106
75,000 sharesCommon SharesTSXSEDI:4560136
Common SharesTSXSEDI:4560132
150,000 sharesCommon SharesTSXSEDI:4553154
100,000 sharesCommon SharesTSXSEDI:4553301
50,000 sharesCommon SharesTSXSEDI:4553304
100,000 sharesCommon SharesTSXSEDI:4553153
Common SharesTSXSEDI:4542859
37,500 shares@ CA$0.20100.0% of flowCommon SharesTSXSEDI:4531750
150,000 shares@ CA$0.20100.0% of flowCommon SharesTSXSEDI:4529869
Common SharesTSXSEDI:4529212
25,000 shares@ CA$0.20100.0% of flowCommon SharesTSXSEDI:4529213
100,000 shares@ CA$0.2045.3% of flowCommon SharesTSXSEDI:4528850
50,000 shares@ CA$0.2067.5% of flowCommon SharesTSXSEDI:4528309
Common SharesTSXSEDI:4516213
25 of 48 declarations
About Cytophage Technologies Ltd.
Cytophage Technologies Ltd. is a company focused on developing innovative technological solutions for the biotechnology sector. It is listed on the Toronto Stock Exchange (XTSE).
